141 related articles for article (PubMed ID: 24781181)
1. [Therapeutic modalities for the management of cough associated with acute respiratory viral infection, effective in an otolaryngologist's practice].
Ovchinnikov AI; Paniakina MA; Korostelev SA; Mitiuk AM
Vestn Otorinolaringol; 2014; (2):86-9. PubMed ID: 24781181
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of Ascoril expectorant and other cough formula in the treatment of cough management in paediatric and adult patients--a randomised double-blind comparative trial.
Jayaram S; Desai A
J Indian Med Assoc; 2000 Feb; 98(2):68-70. PubMed ID: 11016157
[TBL] [Abstract][Full Text] [Related]
3. [Results of international multicentre non-interventional clinical study of the effectiveness and safety of ascoril expectorant for the treatment of cough in Kazakhstan and Uzbekistan].
Nurgozhin TS; Guliaev AE; Ermekbaeva BA; Zhaugasheva SK; Abuova GT; An ÉA
Klin Med (Mosk); 2013; 91(6):50-5. PubMed ID: 24417069
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis].
Zaitsev AA; Leshchenko IV; Esaulova NA; Viktorova IA
Ter Arkh; 2023 Apr; 95(3):236-242. PubMed ID: 37167145
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study.
Prabhu Shankar S; Chandrashekharan S; Bolmall CS; Baliga V
J Indian Med Assoc; 2010 May; 108(5):313-4, 316-8, 320. PubMed ID: 21121410
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of Ascoril in the management of cough--National Study Group report.
Ainapure SS; Desai A; Korde K
J Indian Med Assoc; 2001 Feb; 99(2):111, 114. PubMed ID: 11482804
[TBL] [Abstract][Full Text] [Related]
7. Effect of a single 1200 Mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection.
Bennett WD; Kala A; Duckworth H; Zeman KL; Wu J; Henderson A; Yopp M; Rubin BK
Respir Med; 2015 Nov; 109(11):1476-83. PubMed ID: 26462765
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections.
LaForce C; Gentile DA; Skoner DP
Postgrad Med; 2008 Jul; 120(2):53-9. PubMed ID: 18654069
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
Matthys H; de Mey C; Carls C; Ryś A; Geib A; Wittig T
Arzneimittelforschung; 2000 Aug; 50(8):700-11. PubMed ID: 10994153
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of farcosolvin syrup (ambroxol-theophylline-guaiphenesin mixture) in the treatment of acute exacerbation of chronic bronchitis.
Yakoot M; Salem A; Omar AM
Int J Chron Obstruct Pulmon Dis; 2010 Aug; 5():251-6. PubMed ID: 20714379
[TBL] [Abstract][Full Text] [Related]
11. [The combined drug ascoril in the treatment of patients with chronic obstructive pulmonary disease concurrent with coronary heart disease].
Grigor'eva NIu; Kuznetsov AN; Koroleva TV; Koroleva ME
Ter Arkh; 2013; 85(8):91-4. PubMed ID: 24137971
[TBL] [Abstract][Full Text] [Related]
12. Guaifenesin has no effect on sputum volume or sputum properties in adolescents and adults with acute respiratory tract infections.
Hoffer-Schaefer A; Rozycki HJ; Yopp MA; Rubin BK
Respir Care; 2014 May; 59(5):631-6. PubMed ID: 24003241
[TBL] [Abstract][Full Text] [Related]
13. [Use of the mucoregulator ascoril for respiratory diseases].
Shmeleva NM
Ter Arkh; 2012; 84(10):86-90. PubMed ID: 23227508
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy.
Jeyakumar A; Brickman TM; Haben M
Laryngoscope; 2006 Dec; 116(12):2108-12. PubMed ID: 17146380
[TBL] [Abstract][Full Text] [Related]
15. An in vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol.
Rubin BK
Chest; 1999 Jul; 116(1):195-200. PubMed ID: 10424525
[TBL] [Abstract][Full Text] [Related]
16. Currently available antitussives.
Dicpinigaitis PV
Pulm Pharmacol Ther; 2009 Apr; 22(2):148-51. PubMed ID: 18771744
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for adjunctive symptom relief of acute respiratory infections.
Kikano G
Postgrad Med; 2009 May; 121(3):173-5. PubMed ID: 19491556
[TBL] [Abstract][Full Text] [Related]
18. Question: does guaifenesin improve outcomes in patients with cough associated with upper respiratory infection compared with no intervention?
Ramirez N; Jared M; Hodgden J; Toalson W
J Okla State Med Assoc; 2012 Oct; 105(10):397-8. PubMed ID: 23316675
[No Abstract] [Full Text] [Related]
19. Use of ambroxol and bromhexine as mucolytics for enhanced diffusion of furaltadone into tracheobronchial secretions in broilers.
Sumano H; Gracia I; Capistrán A; Meade G; Rivero A; Ruiz-Ramírez L
Br Poult Sci; 1995 Jul; 36(3):503-7. PubMed ID: 7583380
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antitussive agents in man.
Parvez L; Vaidya M; Sakhardande A; Subburaj S; Rajagopalan TG
Pulm Pharmacol; 1996; 9(5-6):299-308. PubMed ID: 9232667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
